OCUL Past Earnings image   This OCUL past earnings page last updated 5/9/2024
OCUL Past Earnings
PeriodPast Earnings DateAdj. EPS
Q1 20245/7/2024-0.280
Q4 20233/11/2024-0.350
Q3 202311/7/2023-0.250
Q2 20238/7/2023-0.260
Q1 20235/8/2023-0.390
Q4 20223/6/2023-0.240
Q3 202211/7/2022-0.310
Q2 20228/8/2022-0.250
Q1 20225/9/2022-0.220
Q4 20212/28/2022-0.230
Q3 202111/8/2021-0.230
Q2 20218/9/2021-0.250
Q1 20215/5/2021-0.240
Q4 20203/11/2021-1.210
Q3 202011/5/2020-0.210
Q2 20208/7/2020-0.640
Q1 20205/8/2020-0.410
Q4 20193/12/2020-0.530
Q3 201911/12/2019-0.450
Q2 20198/7/2019-0.570
Q1 20195/10/2019-0.450
Q4 20183/7/2019-0.42
Q3 201811/7/2018-0.38
Q2 20188/7/2018-0.37
Q1 20185/8/2018-0.4
Q4 20173/8/2018-0.44
Q3 201711/7/2017-0.54
Q2 20178/8/2017-0.64
Q1 20175/5/2017-0.58
Q4 20163/10/2017-0.52
Q3 201611/9/2016-0.39
Q2 20168/9/2016-0.46
Q1 20165/10/2016-0.44
Q4 20153/10/2016-0.43
Q3 201511/10/2015-0.47
Q2 20158/10/2015-0.45
Q1 20155/15/2015-0.35
Q4 20143/10/2015-0.37
Q3 201411/12/2014-0.48
Q2 20148/28/2014-2.1
OCUL Past Revenue
PeriodPast Earnings DateGAAP
Q1 20245/7/20240.01B
Q4 20233/11/20240.01B
Q3 202311/7/20230.02B
Q2 20238/7/20230.02B
Q1 20235/8/20230.01B
Q4 20223/6/20230.01B
Q3 202211/7/20220.01B
Q2 20228/8/20220.01B
Q1 20225/9/20220.01B
Q4 20212/28/20220.01B
Q3 202111/8/20210.01B
Q2 20218/9/20210.01B
Q1 20215/5/20210.01B
Q4 20203/11/20210.01B
Q3 202011/5/20200.01B
Q2 20208/7/20200.00B
Q1 20205/8/20200.00B
Q4 20193/12/20200.00B
Q3 201911/12/20190.00B
Q2 20198/7/20190.00B
Q1 20195/10/20190.00B
Q4 20183/7/2019504000
Q3 201811/7/2018498000
Q2 20188/7/2018648000
Q1 20185/8/2018340000
Q4 20173/8/2018487000
Q3 201711/7/2017523000
Q2 20178/8/2017438000
Q1 20175/5/2017475000
Q4 20163/10/2017511000
Q3 201611/9/2016477000
Q2 20168/9/2016441000
Q1 20165/10/2016458000
Q4 20153/10/2016436000
Q3 201511/10/2015429000
Q2 20158/10/2015459000
Q1 20155/15/2015426000
Q4 20143/10/2015505000
Q3 201411/12/2014143000
Q2 20148/28/201497000
Quotes delayed 20 minutes

Email EnvelopeFree OCUL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Ocular Therapeutix (OCUL) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

OCUP Past Earnings
OCX Past Earnings
ODT Past Earnings
OFIX Past Earnings
OGN Past Earnings
OLMA Past Earnings
OM Past Earnings
OMER Past Earnings
OMGA Past Earnings
OMI Past Earnings

OCUL Past Earnings Q&A

What was the best and worst OCUL past earnings results?
For Ocular Therapeutix, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest OCUL past earnings result in our data set was -0.210/share posted in Q3 2020, while the lowest was in Q2 2014 when OCUL posted -2.1/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2023 when OCUL reported 0.02B in revenue, while the quarter with the lowest revenue in our data set was Q2 2014 at 97000 of revenue.

  Suggested answer: There are 40 OCUL past earnings results in our data set.

On this page we presented the OCUL past earnings date information for Ocular Therapeutix. Reviewing that OCUL Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2020, when OCUL posted adjusted EPS of -0.210/share. Meanwhile the lowest OCUL past earnings result was in Q2 2014, when OCUL posted adjusted EPS of -2.1/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2023 when OCUL reported 0.02B in revenue, while the smallest revenue quarter was Q2 2014 when OCUL reported 97000 in revenue.

Any self directed investor doing their due diligence on OCUL or any other given stock can benefit from researching all of the Ocular Therapeutix past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Ocular Therapeutix past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for OCUL. Thanks for visiting, and the next time you need to research OCUL past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: WDRW Videos, Institutional Holders of MFH, BDC Options Chain.


OCUL Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.